Two 10-baggers…and counting

Monday, 25 September 2017
Melbourne, Australia
By Bernd Struben

  • Up 1,084% and 991%…oh my!
  • Already saving lives

You’ve probably heard the term ‘10-bagger’.

It’s when a stock goes up 10 times in value from your initial investment, or 900%.

If you invested $200 in a 10-bagger, you’d be sitting on $2,000. Or if you’d invested $2,000, your shares would be worth $20,000. We’re talking about potentially life changing returns here.

Legendary investor Peter Lynch came up with the term 10-bagger in his book, One Up on Wall Street.

You’ve probably heard of Lynch too.

He managed the Fidelity Magellan Fund in the US from 1977-1990. During that time, he became well-known for his investment prowess. When he retired, aged 46, his fund had returned an impressive 29.2% average annual rate of return over that time, according to Investopedia.

Clearly Lynch knew a thing or two about investing. He was also a big fan of baseball. Which is where he came up with his now widely-used term ‘10-bagger’.

You see, a bag is an informal term for a base. That’s because a burlap sack with some sand inside can make a handy makeshift base. A 10-bagger then, would be two home runs and a double. A great day for any player.

Two 10-baggers then, would obviously be monumental.

And this is exactly what Sam Volkering has delivered to his subscribers over at Revolutionary Tech Investor.

We’ll get back to that right after a look at the markets.

Markets

Over the weekend the Dow Jones Industrial Average fell 9.64 points, or 0.04%.

The S&P 500 added 1.62 points, or 0.06%.

In Europe, the Euro Stoxx 50 index finished up 1.83 points, or 0.05%. Meanwhile, the FTSE 100 gained 0.64% and Germany’s DAX index fell 0.06%.

In Asian markets, Japan’s Nikkei 225 index is up 84.86 points, or 0.42%. China’s CSI 300 is down 0.41%.

In Australia, the S&P/ASX 200 is up 7.06 points, or 0.12%.

On the commodities markets, West Texas Intermediate crude oil is US$50.59 per barrel. Brent crude is US$56.83 per barrel.

Gold is trading for US$1,293.58 (AU$1,623.88) per troy ounce. Silver is US$16.95 (AU$21.28) per troy ounce.

One bitcoin is worth US$3,672.81.

The Aussie dollar is worth US79.66 cents.

Up 1,084% and 991%…oh my!

To quickly clear up a common misconception, a return of 1,000% is technically an ‘11-bagger’. That’s because your first 100% gain has already doubled your money.

A return of 1,084% then, is within touching distance of a 12-bagger. And that’s just what Sam’s top stock recommendation had returned when he penned the Revolutionary Tech Investor update last Wednesday.

Now you might think he’s been sitting on that stock for years to get that kind of return. But in fact, this particular revolutionary company shot up almost 12 times in value in only 18 months.

Sam’s second best performing stock,                                         , is no slouch either. The share price has retraced some of its gains from earlier this month. Yet the stock is still up 991% since Sam recommended it to his readers. And that was only 16 months ago, in May 2016.

I don’t have to tell you that these kinds of returns don’t come without risk. And not every revolutionary company Sam tips will shoot the lights out. Some flounder and see their share prices fall.

But when you add in two stocks that have gone up almost 11 and 12 times in the past year and a half — or less — you get an idea of how investing in these kinds of risky stocks can pay off.

It certainly beats the 2.75% annual return you’ll get from your term deposit!

Now these kinds of stocks don’t just fall into Sam’s lap. More than any of our other editors, Sam lives and breathes to uncover the next round of 10-baggers in the fast moving world of technology.

Here’s what he wrote to his subscribers last week:

Our goal here at RTI is actually, very straightforward.

Our mission is to find the most revolutionary technologies in the world. And to bring them to you, so you can invest in them. The aim is to generate more wealth in these opportunities than you’ve ever imagined possible.

It’s the best mandate in the world, as far as we’re concerned.

It means we get to trawl the world to find and uncover opportunities in revolutionary tech that could mint you a fortune.

Whether that’s stocks, crypto or something else we haven’t yet uncovered, it doesn’t matter. If you can invest in it and its revolutionary tech, then we’ll be finding it for you.

This has already lead us to some amazing successes.’

Amazing indeed.

And Sam believes these two 10-plus-baggers have much further to go. While they’re trading above his recommended buy-up-to price, he’s telling his readers to hold onto both stocks.

Who knows? You may hear from me again next year — or sooner — talking about the 20-baggers on Sam’s buy list.

As for the next round of potential 10-baggers, Sam reckons at least one, if not all, of these three recommendations could be joining that exclusive list.

Already saving lives

The three stocks in questions are riding atop the mega-trend of the global legalisation and innovation of marijuana.

And it’s the innovation part that’s so exciting.

It’s not just about investing in the next Anheuser Busch Inbev [NYSE:BUD]. Though if you had gotten into this stock back in January 1978, you’d be looking at an eyepopping gain of 353,669%!

It’s about investing in companies making medical breakthroughs with cannabis trials that were all but impossible to conduct under harsh previous legislations.

Early results with cancer, epilepsy and Crohn’s disease among others, are highly promising. So promising in fact, that Sam believes this is set to be the single biggest medical breakthrough since the discovery and development of penicillin.

Take epilepsy, for example.

It’s a terrible neurological disease that causes debilitating seizures. Even milder cases can have devastating impacts on people’s lives. But severe cases can be fatal.

The case of an 11-year old boy in the UK offers you a great example of just how promising the new treatments derived from cannabis are. Last year he became the first person to receive a prescription for cannabis oil in the UK.

And the results are astonishing.

As the Independent reported earlier this month:

An 11-year-old boy who was dying from severe epilepsy has not had any seizures for 300 days since being prescribed a medical marijuana product.

Billy Caldwell, whose intractable epilepsy means he cannot get help through medication or diet, began treatment with cannabis oil in the US, where medical marijuana is legal, in 2016. 

His prescription was transferred to his local GP, Brendan O’Hare, in Northern Ireland, and Billy became the first person to receive a prescription for medical marijuana in the UK.

The medicine, which contains a compound found in cannabis plants called CBD, does not contain any synthetic chemicals.

The medicine, which contains a compound found in cannabis plants called CBD, does not contain any synthetic chemicals…

His mother, Charlotte Caldwell, said Billy used to suffer up to 100 seizures per day, has now not had a single seizure for 300 days. Ms Caldwell said the cannabis oil has also improved his autism, for example, better eye contact and engagement with books and toys.

“To me, that’s incredible, because one seizure can kill him,” she told ITV News after 90 days of no seizures.’

It’s the kind of story that makes you want to sit up and cheer. And if you’re like me, the kind of story you want to sit up and invest in. Early.

Already, at least 20 North American pot stocks soared more than 1,000% in 2016. But that looks to be only the beginning.

As Sam told me this morning:

 ‘I’m of the firm view the UK will open their doors to legal marijuana, at least medicinally, within the next year. This kid Billy Caldwell is the first to receive a prescription. I reckon the whole country is close.

If Sam’s right — and I think he is — the UK may well provide the next push higher for the best ‘pot stocks’.

Find out Sam’s top three picks here.

Cheers,
Bernd